Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Investigating Clinical Comparability of Two Formulations of Oral Semaglutide in Japanese Participants With Type 2 Diabetes

NCT07271251 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07271251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07271251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Investigating Clinical Comparability of Two Formulations of Oral Semaglutide in Japanese Participants With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2025
Completion date
August 4, 2026
Enrollment
267 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes